Expression of the E2F family in human gastrointestinal carcinomas

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 535-538

  Suzuki, Tetsuo ^a,b   Yasui, Wataru ^a   Yokozaki, Hiroshi ^a   Naka, Kazuhito ^a   Ishikawa, Takenori ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR E2F;

ADULT; AGED; ARTICLE; COLORECTAL CARCINOMA; FEMALE; GASTROINTESTINAL CARCINOMA; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SOUTHERN BLOTTING; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARRIER PROTEINS; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F3 TRANSCRIPTION FACTOR; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032932080     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4     Document Type: Article

References (22)

1. AKAMA, Y., YASUI, W., YOKOZAKI, H., KUNIYASU, H., KITAHARA, K., ISHIKAWA, T. and TAHARA, E., Frequent amplification of the cyclin-E gene in human gastric carcinomas. Jap. J. Cancer Res., 86, 617-621 (1995).
2. BREHM, A., MISKA, E.A., MCCANCE, D.J., REID, J.L., BANNISTER, A.J. and KOUZARIDES, T., Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (Lond.), 391, 597-601 (1998).
3. DYSON, N., The regulation of E2F by pRB-family proteins. Genes Dev., 12, 2245-2262 (1998).
4. GENG, Y., EATON, E.N., PICON, M., ROBERTS, J.M., LUNDBERG, A.S., GIFFORD, A., SARDET, C. and WEINBERG, R.A., Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene, 12, 1173-1180 (1996).
5. HOFMANN, F., MARTELLI, F., LIVINGSTON, D.M. and WANG, Z., The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev., 23, 2949-2959 (1996).
6. HUNT, K.K., DENG, J., LIU, T.-J., WILSON-HEINER, M., SWISHER, S.G., CLAYMAN, G. and HUNG, M.-C., Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian-carcinoma cell lines and does not require p53. Cancer Res., 57, 4722-4726 (1997).
7. HUNTER, T. and PINES, J., Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
8. JAPANESE RESEARCH SOCIETY FOR CANCER OF THE COLON AND RECTUM, General rules for clinical and pathological studies on cancer of the colon, rectum and anus (5th ed.), Kanehara, Tokyo (1994).
9. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER, Japanese classification of gastric carcinoma (1st English ed.), Kanehara, Tokyo (1995).
10. LEE, C.-W., SORENSEN, T.S., SHIKAMA, N. and LA THANGUE, N.B., Functional interplay between p53 and E2F through co-activator p300. Oncogene, 16, 2695-2710 (1998).
11. Kip1, a cyclin-dependent kinase and a potent mediator of extracellular antimitogenic signals. Cell, 78, 59-66 (1994).
12. QIN, X.-Q., LIVINGSTON, D.M., KAELIN, W.G. and ADAMS, P.D., Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. nat. Acad. Sci. (Wash.), 91, 10918-10922 (1994).
13. SAITO, M., HELIN, K., VALENTINE, M.B., GRIFFITH, B.B., WILLMAN, C.L., HARLOW, E. and LOOK, A.T., Amplification of the E2F-1 transcription factor gene in the HEL erythroleukemia cell line. Genomics, 25, 130-138 (1995).
14. SELLERS, W.R., RODGERS, J.W. and KAELIN, W.G., A potent trans-repression domain in the retinoblastoma protein induces cell cycle arrest when bound to E2F sites. Proc. nat. Acad. Sci. (Wash.), 92, 11544-11548 (1995).
15. SOUCEK, T., PUSCH, O., HENGSCHLAGER-OTTNAD, E., ADAMS, P.D. and HENGSTSCHLAGER, M., Deregulated expression of E2F-1 induces cyclin A-and E-associated kinase activities independently from cell-cycle position. Oncogene, 14, 2251-2257 (1997).
16. TROUCHE, D. and KOUZARIDES, T., E2F-1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc. nat. Acad. Sci. (Wash.), 93, 1439-1442 (1996).
17. WEINBERG, R.A., The retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).
18. YAMASAKI, L., JACKS, T., BRONSON, R., GOILLOT, E., HARLOW, E. and DYSON, N.J., Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85, 537-548 (1996).
19. YASUI, W., AKAMA, Y., KUNIYASU, H., YOKOZAKI, H., SHIMAMOTO, F. and TAHARA, E., Expression of cyclin E in human gastric adenocarcinomas: correlation with proliferative activity and p53 status. J. exp. ther. Oncol., 1, 88-94 (1996a).
20. kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jap. J. Cancer Res., 88, 625-629 (1997).
21. YASUI, W., KUNIYASU, H., YOKOZAKI, H., SEMBA, S., SHIMAMOTO, F. and TAHARA, E., Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 and p53 protein. Virchows Arch., 429, 13-19 (1996b).
22. YOSHIDA, K., YOKOZAKI, H., NIIMOTO, M., ITO, H., ITO, M. and TAHARA, E., Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int. J. Cancer, 44, 394-398 (1989).